In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection. Scope of the Report: This report studies the Infectious Disease Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Disease Testing market by product type and applications/end industries. Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media. The global Infectious Disease Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Disease Testing. Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%. Market Segment by Companies, this report covers Abbott Diagnostics Alere Beckman Coulter Diagnostics Roche Siemens Healthcare Abaxis Acon Laboratories Avioq BD Bio-Rad Laboratories Cavidi Cepheid Chembio Diagnostic Systems Clarity Diagnostics EMD Millipore Epitope Diagnostic Gold Standard Diagnostics Hologic Immunetics InBios International Life Technologies? Maxim Biomedical Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Molecular diagnostic test POCT Immunodiagnostic test Market Segment by Applications, can be divided into HIV Respiratory HAIs Sexual health Tropical diseases Hepatitis
Table of Contents 1 Infectious Disease Testing Market Overview 1.1 Product Overview and Scope of Infectious Disease Testing 1.2 Classification of Infectious Disease Testing by Types 1.2.1 Global Infectious Disease Testing Revenue Comparison by Types (2017-2023) 1.2.2 Global Infectious Disease Testing Revenue Market Share by Types in 2017 1.2.3 Molecular diag
